Dr Nigel Garrett earns an honorary Associate Professorship at UKZN
Dr Nigel Garrett (left in the photo) CAPRISA’s Head of HIV Pathogenesis and Vaccine Research has been appointed Honorary Associate Professor in Public Health at the University of KwaZulu-Natal. A Specialist Physician in HIV and Sexual Health, Garrett has conducted more than 20 randomized clinical trials and large cohort studies related to HIV prevention and COVID-19 vaccines.
Garrett trained as a clinician in the UK and completed his PhD in Public Health Medicine in the College of Health Sciences at UKZN, where he now lectures on the biostatistics module “It is a real pleasure to share my experience with students at UKZN while advancing public health in South Africa, “he said.
He played a leading role during the Covid-19 pandemic as Co-Chair of the Sisonke Covid-19 vaccine implementation study and currently serves as the international chair on the COVPN 3008 Ubuntu mRNA vaccine trial and the HVTN108 HIV vaccine study.
Garrett is a Technical Expert Consultant of the South African National Strategic Plan (NSP) Development: NSP for HIV, TB and STIs 2023 – 2028 and provides input on objectives and interventions on reducing STIs, cervical cancer and hepatitis. He is the CAPRISA Investigator of Record for the HIV Vaccine Trials Network (HVTN) studies and Principal Investigator on several HVTN and COVPN vaccine trials. He also leads US National Institute of Health self-initiated grants on point-of-care technology.
Garrett has published more than 100 manuscripts on a range of topics including COVID-19 vaccines, HIV prevention and sexual health. He currently supervises four PhD and three MSc students.